FNY Partners Fund’s GSK GSK Stock Holding History

FNY Partners Fund’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-60,000	Closed	-$3.16M	–	804
2017 Q1	$3.16M	Buy	+60,000	New	+$3.04M	0.36%	42

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

FNY Partners Fund's GSK Position: Q2 2017 in Review

FNY Partners Fund sold out of GSK (GSK) in Q2 2017, closing a stake of 60,000 shares — an estimated $3.16M sold.

FNY Partners Fund first reported a position in GSK in Q1 2017 and held it in 1 quarter. The position peaked at $3.16M in Q1 2017. 779 funds tracked by Wall St. Rank hold GSK as of Q2 2017.

FNY Partners Fund reported no remaining GSK position as of Q2 2017 after selling out during the quarter.
FNY Partners Fund sold 60,000 GSK shares in Q2 2017, an estimated $3.16M.
FNY Partners Fund first reported a position in GSK in Q1 2017 and held it in 1 quarter.
FNY Partners Fund's GSK position peaked at $3.16M in Q1 2017.
779 funds tracked by Wall St. Rank held GSK as of Q2 2017.

Based on FNY Partners Fund's 13F filing for Q2 2017, filed 10 Aug 2017.